Home
About
Services
Partners
Client Portfolio
News
Contact
Nigeria’s oil hub quarantines 22 Exxon Mobil workers: governor
April 17, 2020
GE aircraft leasing unit cancels 69 737 MAX orders
April 17, 2020
0
Gilead’s shares rise on report of experimental drug’s promise in COVID-19
Published by
Muller&Green
at
April 17, 2020
Categories
RSS
Tags
Shares of Gilead Sciences Inc rose 8% on Friday after a report that patients with COVID-19 treated with the company’s experimental drug, remdesivir, in a clinical trial showed rapid recovery in fever and respiratory symptoms.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more